800-TEMPLE-MED

You are here

Home » Patient Care » Centers & Programs » Advanced Heart Failure, Circulatory Support, & Transplantation Program » Treatments
Resize Text

Clinical Trials May Offer Hope for Patients with Heart Failure

The Temple Heart & Vascular Institute enrolls numerous patients in clinical trials each year. Learn more about the heart failure related clinical trials that are currently offered at Temple.

Browse Clinical Trials

Treatments

At the Temple Advanced Heart Failure and Transplantation Program, you will receive an immediate evaluation and access to an array of diagnostic and therapeutic services as part of a full continuum of care.

Temple’s advanced procedures and therapies include:

Related News
Walter J. Koch, PhD
Posted Tuesday, April 3, 2018

Temple’s Dr. Walter Koch Receives Prestigious $1 Million AHA Merit Award to Investigate Molecular Signaling by the Heart

Research funded by the award will focus on the heart as an endocrine organ that regulates body fat.
View Story
Posted Monday, July 3, 2017

Temple Researchers Identify Novel Mechanism Underlying Efficacy of Common Heart Failure Drug

Beta-blocker drugs serve a key role in the treatment of heart failure, preventing bombardment of the heart by catecholamines – substances like epinephrine and norepinephrine – which...
View Story
Posted Wednesday, March 2, 2016

Temple Researchers Uncover Novel Mechanism behind Aldosterone-Induced Heart Damage

When the heart begins to fail, the body does everything in its power to fix the situation. But sometimes, those compensatory mechanisms ultimately do more harm than good. Such is the case with the...
View Story
Patient Stories
Alicia with her daughter

Alicia's Story

Until she fainted in 2012, Alicia didn’t know she was sick. Feeling tired and out of breath were “normal for me,” says the now 52-year-old single mom. The Glenside resident believed she felt that way because she was overweight and out of shape. She was working 10- to 12-hours daily attending her daughter Shannon’s high school track meets and working part-time on an online MBA degree.
Read More
Brian sitting on a couch

Brian's Story

After suffering a seizure in 2000, Brain learned that a virus had destroyed the lower third of his heart. He received a defibrillator and a dual pacemaker. More than a decade later, his heart function began to deteriorate further. So his doctors in the Lehigh Valley recommended that Brian go to the Temple Heart & Vascular Institute—where, at the age of 70, he received a heart transplant in December 2013.
Read More
portrait of Jim

Jim's Story

Just nine months after receiving a heart transplant at the Temple Heart and Vascular Institute, Jim, a professional actor, was back on stage—playing Daddy Warbucks in the musical “Annie.”
Read More
Clinical Trials

Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)

Over the last two decades, MCSDs have been developed to augment or supplant failing myocardial performance. This therapy has been used successfully as a bridge to heart transplantation, a bridge to recovery, and as permanent implantation or "destination therapy" for intractable heart failure. Although heart transplantation offers life-saving therapy for selected patients, its use is limited by a supply of donor organs that currently meets less than one-tenth the need. As a consequence, the number of MCSD implantations has increased in recent years.
Read More

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads (QP ExCELs)

The QP ExCELs study is designed to confirm safety and efficacy of the BIOTRONIK Sentus OTW QP left ventricular leads to satisfy FDA requirements for regulatory approval of the leads in the US. ...
Read More

Genomic Response Analysis of Heart Failure Therapy in African Americans (GRAHF-2)

The response to therapy with a fixed dose combination of isosorbide dinitrate and hydralazine (FDC I/H) is enhanced in African Americans with heart failure and reduced ejection fraction (HFrEF) when...
Read More